Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud's phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder.

Authors :: Hughes M
Umair HM
Sandler RD
Alunno A
Matucci-Cerinic M
Source :: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2022 Dec; Vol. 57, pp. 152114. Date of Electronic Publication: 2022 Oct 21.
Publication Year :: 2022
Abstract: Competing Interests: Declaration of Competing Interest None by any of the authors.

Subjects :: Humans
Adrenergic Antagonists
Ischemia complications
Ischemia drug therapy
Central Nervous System Stimulants
Attention Deficit Disorder with Hyperactivity complications
Attention Deficit Disorder with Hyperactivity drug therapy
Raynaud Disease complications
Raynaud Disease drug therapy

Full Text Access

Tools